| 
             
			
			 The Mobile Research Unit (MRU) arrived Thursday at 
			St. Clara’s to begin the trial study. Heritage Operations Group, 115 
			W. Jefferson Street, Bloomington – manages the operations of St. 
			Clara’s and has entered into an agreement to partner with drug 
			manufacturer, Eli Lilly and Company of Indianapolis (NYSE: LLY) to 
			initiate this drug trial named BLAZE-2 of their COVID-19 antibody 
			drug currently called LY-CoV555. This trial is study the use of the 
			drug to be used for the prevention of SARS-CoV-2 infection and 
			COVID-19 in residents and staff of skilled nursing, assisted living 
			and supportive living facilities. 
			 
			
			  
			All Heritage owned and managed skilled nursing, assisted and 
			supportive living facilities are potential test site candidates in 
			this Phase 3 trial. “We are thrilled to be working with Eli Lilly 
			and assisting them on their development of this potentially 
			important COVID-19 treatment. So far, we have been able to offer few 
			options other than infection control measures and palliative care. 
			This partnership with Eli Lilly offers our residents and employees a 
			sense of hope, and gives us an opportunity to be on the offensive 
			against this terrible disease, which has disproportionately impacted 
			the elderly population,” said Ben Hart, president and CEO of 
			Heritage Operations Group. 
			 “COVID-19 has had a devastating impact on nursing 
			home residents. We’re working as fast as we can to create medicines 
			that might stop the spread of the virus to these vulnerable 
			individuals,” said Daniel Sovronsky, M.D., Ph.D., said Eli Lilly’s 
			chief scientific officer and president of Lilly Research 
			Laboratories. Eli Lilly’s study of this antibody drug is 
			experimental, and participation by residents and staff is voluntary.
			 
            [to top of second column]  | 
            
             
            
			  
            Upon meeting certain COVID positive criteria, Eli 
			Lilly will deploy a mobile research unit (MRU) to the facility and 
			conduct an infusion clinic onsite. This process would be coordinated 
			by staff at the Heritage corporate office. A research team 
			consisting of approximately ten Eli Lilly staff (coordinators, 
			physician assistants, infusion RNs, medical technicians) would 
			conduct all trial operations.  
			 
			Heritage Operations Group, LLC is a division of Heritage 
			Enterprises, Inc., which was founded in 1962 and is involved in a 
			variety of residential and health care services for seniors. The 
			company opened the first nursing home in Bloomington, Illinois, 
			where Heritage is headquartered. Today, the company employs over 
			4,300 people and owns or manages over 50 facilities throughout 
			Illinois. Heritage offers RESTORE therapy services, skilled nursing 
			services, sheltered care, respite care. Additionally, Heritage owns 
			and manages supportive living, licensed assisted living and 
			independent living facilities. For more information about Heritage, 
			please visit www.HeritageOfCare.com. 
            [Melissa A. Beaver, MBA 
			Vice President – Community Relations & Marketing 
			Heritage Operations Group, LLC] 
               |